- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03785444
Comparison of Self-assessment vs. Assessment by Others of Critically Ill Patients (ASTON)
October 5, 2020 updated by: Technical University of Munich
Agreement in Relatives' Assessment in Standardized Questionnaires of Patients Who Have Been Admitted to Intensive Care Compared to Patients Who Have Not Been Admitted to Intensive Care (ASTON Study)
We will test the results of standardized questionnaires for patients admitted to intensive care assessed by relatives/caregivers compared to the patient itself.
Furthermore we will compare results with patients not admitted to intensive care.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
200
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Berlin, Germany, 13353
- Charité - Universitätsmedizin Berlin
-
-
Bavaria
-
Munich, Bavaria, Germany, 81675
- Klinikum rechts der Isar, School of Medicine, Technical University of Munich
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Surgical patients with a high risk to be admitted to intensive care
Description
Inclusion Criteria:
- patient with a postoperative risk to be admitted to intensive care
- signed informed consent
Exclusion Criteria:
- patient who is not able to fill out the questionnaires alone and independent
- patient without relatives or a caregiver who could answer the assessment after surgery
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Intensive Care Patients
Postoperative patients who have been admitted to intensive care
|
WHO Disability Score
Health related quality of life measured with European Quality of Life 5 Dimensions 5 Level
The Lawton Instrumental Activities of Daily Living
Barthel Score of the patient
Short Form Health 36
Montreal Cognitive Assessment
|
|
Non-Intensive Care Patients
Postoperative patients who have not been admitted to intensive care but to the normal ward
|
WHO Disability Score
Health related quality of life measured with European Quality of Life 5 Dimensions 5 Level
The Lawton Instrumental Activities of Daily Living
Barthel Score of the patient
Short Form Health 36
Montreal Cognitive Assessment
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Agreement in assessment of ICU patients
Time Frame: 2 weeks before hospital admission
|
Comparison of results of self-assessment versus assessment by others of standardized questionnaires of postoperative patients admitted to intensive care
|
2 weeks before hospital admission
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Agreement in assessment of ICU vs. non-ICU patients
Time Frame: 2 weeks before hospital admission
|
Comparison of results of assessment of questionnaires of ICU patients vs. non-ICU patients
|
2 weeks before hospital admission
|
|
Agreement in assessment of non-ICU patients
Time Frame: 2 weeks before hospital admission
|
Comparison of results of self-assessment versus assessment by others of standardized questionnaires of postoperative patients not admitted to intensive care but to the normal ward
|
2 weeks before hospital admission
|
|
Multivariate testing using the closeness of the relationship
Time Frame: 2 weeks before hospital admission
|
It will be tested if the closeness of relationship patient - relative/caregiver changes the agreement, i.e. if the agreement is dependent or independent of the closeness of the relationship
|
2 weeks before hospital admission
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Definition of criteria which define an appropriate close relationship to receive a reliable test result
Time Frame: 2 weeks before hospital admission
|
Test which closeness of relationship is sufficient to provide adequate test results compared with the patient's answers
|
2 weeks before hospital admission
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Steffen Weber-Carstens, MD, Charite University, Berlin, Germany
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 25, 2019
Primary Completion (Actual)
August 15, 2020
Study Completion (Actual)
August 15, 2020
Study Registration Dates
First Submitted
December 17, 2018
First Submitted That Met QC Criteria
December 19, 2018
First Posted (Actual)
December 24, 2018
Study Record Updates
Last Update Posted (Actual)
October 6, 2020
Last Update Submitted That Met QC Criteria
October 5, 2020
Last Verified
October 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- ASTON
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
IPD Plan Description
Anonymized data will be made available to other researchers on reasonable request. A data share agreement will have to be signed by both parties.
Examples of reasonable requests are:
- a metaanalysis in the field
- a research collaboration
- rerun the analysis
Data will only be provided for the purpose requested and may not be used otherwise without authorization/agreement.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.